AVOSENTAN

UNII:	L94KSX715K
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₃H₂₁N₅O₅S
Preferred Substance Name:	AVOSENTAN
InChIKey:	YBWLTKFZAOSWSM-UHFFFAOYSA-N
GSRS Full Record:	L94KSX715K i

290815-26-8
2-PYRIDINESULFONAMIDE, N-(6-METHOXY-5-(2-METHOXYPHENOXY)-2-(4-PYRIDINYL)-4-PYRIMIDINYL)-5-METHYL-
Avosentan [WHO-DD]
N-(6-METHOXY-5-(2-METHOXYPHENOXY)-2-(PYRIDIN-4-YL)PYRIMIDIN-4-YL)-5-METHYLPYRIDINE-2-SULFONAMIDE
N-[6-methoxy-5-(2-methoxyphenoxy)-2-pyridin-4-ylpyrimidin-4-yl]-5-methylpyridine-2-sulfonamide
N-[6-methoxy-5-(2-methoxyphenoxy)-2-pyridin-4-ylpyrimidin-4-yl]-5-methylpyridine-2-sulfonamide
RO 67-0565
RO-67-0565
SPP-301
avosentan [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

AVOSENTAN

Synonyms and Mappings

Resources